Research Article
Electroacupuncture and Rosiglitazone Combined Therapy as a Means of Treating Insulin Resistance and Type 2 Diabetes Mellitus: A Randomized Controlled Trial
Table 1
Baseline data obtained from the intention-to-treat patients in the experimental (TZD + EA) and placebo groups (TZD).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
All values are shown as mean ± SEM except for the use of oral hypoglycemic agents (OHA); TZD + EA = experimental group, who were patients that received 8 mg rosiglitazone and electroacupuncture; TZD = placebo group, who were patients that received 8 mg rosiglitazone only. Independent groups were compared using the nonparametric Mann-Whitney test. NS, means no significant difference, . |